[{"Assets_0_Q2_USD":1434283000.0,"CommonStockSharesOutstanding_0_Q2_shares":91701397.0,"NetIncomeLoss_1_Q2_USD":-118420000.0,"NetIncomeLoss_2_Q2_USD":-225710000.0,"StockholdersEquity_0_Q2_USD":1122966000.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]